The burden of gastrointestinal disease: implications for the provision of care in the UK

M. D. Hellier; Williams, J. G.
February 2007
Gut;Feb2007, Vol. 56 Issue 2, p165
Academic Journal
The article discusses the implications of gastrointestinal disease in the provision of care in Great Britain. The author reflects that gastrointestinal and liver diseases are common but have been given little attention from a policy perspective. He mentions that the National Health Service Cancer Plan will be disadvantageous to some patients but will improve services for others. He opines that development of future services is dependent upon good research and challenges to gastroenterologists.


Related Articles

  • Shark cartilage in the water. Waxman, Jonathan // BMJ: British Medical Journal (International Edition);11/25/2006, Vol. 333 Issue 7578, p1129 

    This article provides a look at a list created by Great Britain's National Health Service Directory of Complementary and Alternative Practitioners of directories that offer alternative medicine for cancer patients, such as "Flower Therapy" and "Dowsing." Alternative medicine is popular because...

  • Up in arms over cancer confusion. Peverley, Phil // Pulse;9/9/2009, Vol. 69 Issue 28, p36 

    The article offers information about cancer prescription charges. It notes that the National Health Service (NHS) website does not mention cancer in the list of qualifying medical conditions. It is conceded that the interpretation of the term cancer is far from straightforward, unless the...

  • NHS faces legal action on payments by patients for private drugs while receiving NHS care. Dyer, Clare // BMJ: British Medical Journal (International Edition);6/7/2008, Vol. 336 Issue 7656, p1265 

    The article presents an overview of legal action that Great Britain's National Health Service (NHS) may face from the country's High Court in 2008. The action will be concerned with cancer patients' right to increase their care with drugs privately paid for as they receive free cancer treatment...

  • Cancer care in the United Kingdom: new solutions are needed. Sikora, Karol; Bosanquet, Nick // BMJ: British Medical Journal (International Edition);11/1/2003, Vol. 327 Issue 7422, p1044 

    Reports on the failure of the National Health Service (NHS) Cancer Plan. Plan which set out to treat cancer patients within two months of referral; Progress report; Failure to meet the target; Reasons for the failure which center on shortages of staff and equipment; Future demands which are...

  • Using open mornings to develop cancer networks as learning organisations. Handscomb, Karen // Nursing Management - UK;Jun2006, Vol. 13 Issue 3, p26 

    The article presents information on cancer networks which are unique organisations established in the National Health Service Cancer Plan in Great Britain to further integrate care for patients with cancer. The Mount Vernon Cancer Network links a cancer centre, district general hospitals and...

  • Hepatitis B infections. Beeching, Nicholas J. // BMJ: British Medical Journal (International Edition);11/6/2004, Vol. 329 Issue 7474, p1059 

    Presents an editorial on the need for universal immunisation for hepatitis B infections in Great Britain. Statistics on the number of cases worldwide and in the United Kingdom; Estimated cost of treatment to the National Health Service which is £26m-£375m per year; How immunization policy...

  • Gordon Brown turns waiting time targets into a patient's right in draft legislative programme. Mooney, Helen // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/4/2009, Vol. 339 Issue 7711, p10 

    The article reports on the right of National Health Service (NHS) patients in England who have suspected cancer to see a specialist within two weeks under a draft legislative programme of the government of British Prime Minister Gordon Brown. Under the programme, primary care trusts will be...

  • Watchdog set to reject four kidney cancer drugs for NHS. O'Dowd, Adrian // BMJ: British Medical Journal (International Edition);8/16/2008, Vol. 337 Issue 7666, p371 

    The article reports on a decision from Great Britain's National Institute for Health and Clinical Excellence to consider not allowing the country's National Health Service to offer the drugs sunitib, bevacizumab, sorafenib and temsirolimus to patients with advanced renal cancer. The institute...

  • 'Improve access to head cancer nurses'  // Nursing Standard;8/12/2009, Vol. 23 Issue 49, p10 

    The article reports on the results of Great Britain's National Head and Neck Cancer Audit, which analyzed the medical care records of patients from National Health Service trusts in England and Wales between November of 2007 and October of 2008. The audit found that there is a shortage of...


Read the Article


Sign out of this library

Other Topics